Allegion (NYSE:ALLE) Price Target Raised to $170.00 at JPMorgan Chase & Co.

Allegion (NYSE:ALLE) had its target price raised by research analysts at JPMorgan Chase & Co. from $150.00 to $170.00 in a note issued to investors on Friday,Benzinga reports. The brokerage currently has a “neutral” rating on the scientific and technical instruments company’s stock. JPMorgan Chase & Co.‘s target price would suggest a potential upside of 10.14% from the stock’s previous close.

Other analysts have also recently issued research reports about the stock. Wells Fargo & Company lowered their price objective on shares of Allegion from $175.00 to $155.00 and set an “equal weight” rating on the stock in a research report on Wednesday, April 1st. Morgan Stanley cut their target price on shares of Allegion from $165.00 to $142.00 and set an “equal weight” rating for the company in a research report on Wednesday, June 3rd. Weiss Ratings cut Allegion from a “hold (c+)” rating to a “hold (c)” rating in a research note on Friday, May 29th. Robert W. Baird set a $170.00 price target on Allegion in a research report on Friday. Finally, Bank of America reduced their price objective on Allegion from $185.00 to $157.00 and set a “neutral” rating on the stock in a research report on Monday, April 20th. One investment analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and nine have given a Hold rating to the company’s stock. According to MarketBeat, Allegion has a consensus rating of “Hold” and a consensus price target of $163.67.

Allegion Stock Performance

Shares of NYSE:ALLE traded down $0.22 during trading on Friday, hitting $154.35. 779,493 shares of the company were exchanged, compared to its average volume of 1,041,156. Allegion has a 52-week low of $125.00 and a 52-week high of $183.11. The stock has a 50 day moving average of $134.25 and a 200 day moving average of $146.77. The company has a debt-to-equity ratio of 0.97, a current ratio of 1.91 and a quick ratio of 1.19. The company has a market cap of $13.27 billion, a PE ratio of 21.13, a P/E/G ratio of 2.90 and a beta of 0.85.

Allegion (NYSE:ALLE) last issued its quarterly earnings data on Thursday, July 23rd. The scientific and technical instruments company reported $2.40 EPS for the quarter, beating the consensus estimate of $2.22 by $0.18. The company had revenue of $1.15 billion during the quarter, compared to analysts’ expectations of $1.12 billion. Allegion had a net margin of 15.24% and a return on equity of 35.41%. Allegion’s revenue for the quarter was up 12.7% on a year-over-year basis. During the same quarter in the previous year, the company earned $2.04 earnings per share. Allegion has set its FY 2026 guidance at 8.850-9.000 EPS. As a group, equities research analysts predict that Allegion will post 8.75 EPS for the current year.

Allegion announced that its Board of Directors has authorized a share repurchase plan on Tuesday, April 28th that authorizes the company to buyback $500.00 million in outstanding shares. This buyback authorization authorizes the scientific and technical instruments company to reacquire up to 3.9% of its shares through open market purchases. Shares buyback plans are often a sign that the company’s management believes its stock is undervalued.

Insider Buying and Selling at Allegion

In related news, SVP Robert C. Martens sold 3,993 shares of the company’s stock in a transaction on Thursday, May 7th. The stock was sold at an average price of $137.15, for a total value of $547,639.95. Following the sale, the senior vice president directly owned 8,570 shares of the company’s stock, valued at $1,175,375.50. This represents a 31.78% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 0.64% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in ALLE. Handelsbanken Fonder AB boosted its stake in Allegion by 43.0% in the 2nd quarter. Handelsbanken Fonder AB now owns 38,900 shares of the scientific and technical instruments company’s stock worth $5,465,000 after purchasing an additional 11,700 shares in the last quarter. Franklin Street Advisors Inc. NC lifted its stake in shares of Allegion by 16.2% in the second quarter. Franklin Street Advisors Inc. NC now owns 2,384 shares of the scientific and technical instruments company’s stock worth $335,000 after buying an additional 332 shares in the last quarter. Crumly & Associates Inc. lifted its stake in shares of Allegion by 20.8% in the second quarter. Crumly & Associates Inc. now owns 2,580 shares of the scientific and technical instruments company’s stock worth $362,000 after buying an additional 444 shares in the last quarter. Elevation Wealth Partners LLC grew its holdings in shares of Allegion by 1,666.7% during the second quarter. Elevation Wealth Partners LLC now owns 212 shares of the scientific and technical instruments company’s stock valued at $30,000 after buying an additional 200 shares during the last quarter. Finally, Czech National Bank increased its position in shares of Allegion by 4.4% during the second quarter. Czech National Bank now owns 24,461 shares of the scientific and technical instruments company’s stock valued at $3,437,000 after acquiring an additional 1,031 shares in the last quarter. Hedge funds and other institutional investors own 92.21% of the company’s stock.

Key Headlines Impacting Allegion

Here are the key news stories impacting Allegion this week:

• Positive Sentiment: Allegion reported Q2 2026 EPS of $2.40, beating estimates, while revenue of $1.15 billion also topped expectations and rose 12.7% year over year. Allegion (NYSE: ALLE) Reports Q2-2026 Financial Results
• Positive Sentiment: The company raised its FY2026 guidance, signaling confidence in continued demand and margin improvement, especially in the Americas. Allegion Shares Up After Raising FY26 Revenue, Adjusted EPS Views
• Positive Sentiment: Management highlighted organic growth and margin expansion in the Americas, and noted signs of recovery in the international segment, supporting the view that the business momentum is broadening. Allegion: Keep Calm And Lock In
• Neutral Sentiment: Recent commentary from analysts and news outlets has focused on Allegion’s long-term growth profile and valuation, with some calling the stock attractive after the earnings move. Why Allegion (ALLE) Is a Top Growth Stock for the Long-Term
• Neutral Sentiment: Allegion also disclosed a routine risk update in its latest filing, but it did not appear to introduce a material new issue for investors. Allegion PLC Signals Stable Risk Profile but Offers Limited New Transparency Beyond 2025 Form 10-K

About Allegion

Allegion plc (NYSE: ALLE) is a global provider of security products and solutions focused on ensuring the safety and security of people and property. The company was formed in December 2013 through a corporate spin-off from Ingersoll Rand and is head­quartered in Dublin, Ireland. Allegion’s core mission is to deliver innovative mechanical and electronic access control systems for a wide range of end markets, including commercial buildings, residential properties, institutional facilities, and industrial sites.

The company’s product portfolio spans mechanical locksets, door closers, exit devices, key systems and cylinders, as well as a growing suite of electronic and smart access control offerings.